Eylea HD 8 MG/0.07 ML vial 0.07ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFBY4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,263
Award facts
- Contract value 100% obligated
- $29,263.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $29,263.05 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA HD 8 mg/0.07 mL vials. This delivery order, issued on January 22, 2026, with an ultimate completion date of February 12, 2026, was made without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The award was funded by the DLA and leverages DMS Pharmaceutical Group's established position as a critical supplier within the federal pharmaceutical supply chain.
This delivery order operates under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $500 million ceiling and extends through December 31, 2036. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to provide the Department of Defense with comprehensive pharmaceutical supply support globally, including branded and generic prescription drugs, biologics, and medical consumables. DMS Pharmaceutical Group serves as a regional prime vendor contractor under this program, with no subcontractors identified, and has demonstrated substantial performance across diverse therapeutic categories supporting military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26FFBY4?
SPE2DR26FFBY4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FFBY4 worth?
The government has obligated $29,263 on SPE2DR26FFBY4.
Is contract SPE2DR26FFBY4 an order under another contract?
Yes. SPE2DR26FFBY4 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBY4 competed?
The extent of competition for SPE2DR26FFBY4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award